Effects of the COVID-19 pandemic on breast cancer screening in Taiwan
- PMID: 32919172
- PMCID: PMC7470863
- DOI: 10.1016/j.breast.2020.08.014
Effects of the COVID-19 pandemic on breast cancer screening in Taiwan
Abstract
The breast cancer screening program has continued in Taiwan during the COVID-19 pandemic. Our nationwide data showed that the total number of screenings decreased by 22.2%, which was more pronounced for in-hospital examinations (-37.2%), while outreach showed a 12.9% decrease. This decline in screening participation happened at all levels of hospitals, more significantly at the highest level. Our report revealed that outreach services could maintain relatively stable breast cancer screening under this kind of public health crisis. Building a flexible, outreach system into the community might need to be considered when policymakers are preparing for future possible pandemics.
Keywords: Breast cancer screening; COVID-19; Mammography; Outreach.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Figures
References
-
- Wilson R. COVID-19 sidelines breast cancer screening. Oncol Times. 2020;42:14.
-
- Wang C.J., Ng C.Y., Brook R.H. Response to COVID-19 in taiwan: big data analytics, new technology, and proactive testing. J Am Med Assoc. 2020;323:1341–1342. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
